» Articles » PMID: 36609826

Common and Rare Variants in TMEM175 Gene Concur to the Pathogenesis of Parkinson's Disease in Italian Patients

Abstract

Parkinson's disease (PD) represents the most common neurodegenerative movement disorder. We recently identified 16 novel genes associated with PD. In this study, we focused the attention on the common and rare variants identified in the lysosomal K channel TMEM175. The study includes a detailed clinical and genetic analysis of 400 cases and 300 controls. Molecular studies were performed on patient-derived fibroblasts. The functional properties of the mutant channels were assessed by patch-clamp technique and co-immunoprecipitation. We have found that TMEM175 was highly expressed in dopaminergic neurons of the substantia nigra pars compacta and in microglia of the cerebral cortex of the human brain. Four common variants were associated with PD, including two novel variants rs2290402 (c.-10C > T) and rs80114247 (c.T1022C, p.M341T), located in the Kozak consensus sequence and TM3II domain, respectively. We also disclosed 13 novel highly penetrant detrimental mutations in the TMEM175 gene associated with PD. At least nine of these mutations (p.R35C, p. R183X, p.A270T, p.P308L, p.S348L, p. L405V, p.R414W, p.P427fs, p.R481W) may be sufficient to cause the disease, and the presence of mutations of other genes correlated with an earlier disease onset. In vitro functional analysis of the ion channel encoded by the mutated TMEM175 gene revealed a loss of the K conductance and a reduced channel affinity for Akt. Moreover, we observed an impaired autophagic/lysosomal proteolytic flux and an increase expression of unfolded protein response markers in patient-derived fibroblasts. These data suggest that mutations in TMEM175 gene may contribute to the pathophysiology of PD.

Citing Articles

Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease.

Schulze T, Rauh O, Thiel G, Fertig N, Bazzone A, Grimm C J Cell Physiol. 2025; 240(2):e70008.

PMID: 39902728 PMC: 11792109. DOI: 10.1002/jcp.70008.


Multiomics approach identifies dysregulated lipidomic and proteomic networks in Parkinson's disease patients mutated in TMEM175.

Carrillo F, Ghirimoldi M, Fortunato G, Palomba N, Ianiro L, De Giorgis V NPJ Parkinsons Dis. 2025; 11(1):23.

PMID: 39856101 PMC: 11760379. DOI: 10.1038/s41531-024-00853-5.


What We Know About TMEM175 in Parkinson's Disease.

Wang J, Sun X, Cheng L, Qu M, Zhang C, Li X CNS Neurosci Ther. 2025; 31(1):e70195.

PMID: 39834146 PMC: 11746916. DOI: 10.1111/cns.70195.


Lysosome quality control in health and neurodegenerative diseases.

Ferrari V, Tedesco B, Cozzi M, Chierichetti M, Casarotto E, Pramaggiore P Cell Mol Biol Lett. 2024; 29(1):116.

PMID: 39237893 PMC: 11378602. DOI: 10.1186/s11658-024-00633-2.


Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types.

Holtman I, Glass C, Nott A Adv Neurobiol. 2024; 37:531-544.

PMID: 39207711 DOI: 10.1007/978-3-031-55529-9_29.


References
1.
Bloem B, Okun M, Klein C . Parkinson's disease. Lancet. 2021; 397(10291):2284-2303. DOI: 10.1016/S0140-6736(21)00218-X. View

2.
Chen A, Chen L, Kim T, Xiong Q . Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease. Biomedicines. 2021; 9(6). PMC: 8228225. DOI: 10.3390/biomedicines9060647. View

3.
Stefanis L . α-Synuclein in Parkinson's disease. Cold Spring Harb Perspect Med. 2012; 2(2):a009399. PMC: 3281589. DOI: 10.1101/cshperspect.a009399. View

4.
Langston J, Schule B, Rees L, Nichols R, Barlow C . Multisystem Lewy body disease and the other parkinsonian disorders. Nat Genet. 2015; 47(12):1378-84. DOI: 10.1038/ng.3454. View

5.
Verstraeten A, Theuns J, Van Broeckhoven C . Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet. 2015; 31(3):140-9. DOI: 10.1016/j.tig.2015.01.004. View